In an effort to limit acquisition of extraneous targets with HSPPC-96, synthetic immunogenic melanoma peptides -- such as MART-1, gp100, or MAGE-- have been bound to cloned HSP-96 and other chaperones, such as HSP-70 [25,26]. The gene discussed is PMEL; the disease is melanoma.